Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Wieshammer, J. Dreyhaupt, B. Basler (Offenburg, Heidelberg, Germany). Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide. Eur Respir J 2007; 30: Suppl. 51, 3300

Member's Comments

No comment yet.

Related content which might interest you: Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010 N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 509-513 Year: 2005 Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003 Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management Year: 2006 Τhe influence of pulmonary disease on ventricular diastolic dysfunction in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003 Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Prognostic value of ventricular volumes and function in patients with pulmonary hypertension due to chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging Year: 2012 Echocardiographic predictors of stress induced right ventricular diastolic dysfunction in non-severe  chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function Year: 2020 Diagnosis of left ventricular diastolic dysfunction using echocardiography in COPD patients with pulmonary arterial hypertension Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Resistin, 8-isorpostanes and stress right ventricular diastolic dysfunction -   predictors for exacerbations in non-severe chronic obstructive pulmonary disease patients Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Right ventricular (RV) diastolic function in patients with pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 26s Year: 2002 Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities II Year: 2012